Amar supports technology and life sciences clients of all stages on patent prosecution matters.

Prior to joining Fenwick, Amar was a patent agent at a premier provider of legal services to technology and life sciences companies, where he drafted and prosecuted U.S. and international patent applications with a particular focus on gene therapies, molecular biology, and regenerative medicine. Before transitioning to patent law, he led the development of gene therapies targeting age-related diseases at a prominent biotechnology company aiming to extend human healthspans. Amar completed his doctorate at the University of Cambridge, where he designed experimental gene therapies to rejuvenate aging neural stem cells and restore the regenerative capacity of the aged central nervous system.